Former FDA Adviser Draws Attention to Complications With LASIK

Image for post
Image for post

LASIK eye surgery has been around for more than 20 years, but a growing number of people have raised concerns about the procedure. Among them is Dr. Morris Waxler, a retired Food and Drug Administration advisor who voted to approve LASIK in the 1990s.

Last week, Waxler told CBS News that the procedure should be taken off the market.

“Essentially we ignored the data on vision distortions that persisted for years,” Waxler told CBS This Morning in a segment that ran on Nov. 14. “I re-examined the documentation…and I said, ‘Wow this is not good.’”

Laser-assisted in situ Keratomileusis, commonly known as LASIK, is a minimally-invasive surgery that uses a laser to reshape the cornea, the clear front surface of the eye, in order to improve vision. CBS News estimates that an estimated 20 million LASIK procedures have been performed since it was approved.

Image for post
Image for post

According to CBS News, Waxler petitioned the FDA in 2011to voluntarily recall its approval of LASIK, which was denied. The FDA told CBS it “has not found any new safety concerns associated with LASIK devices.”

However, Waxler’s analysis of industry data suggests up to 30% of patients experience complications. A 2017 study published in JAMA Ophthalmology found that nearly half of patients who underwent LASIK experienced a new visual symptom post-surgery.

The FDA’s website reports some of these complications include dry eyes, blurred vision, visual symptoms such as glare or halos, double vision or trouble seeing at night and even a possible loss of vision. The New York Times found that other recent studies suggested LASIK patients “may also be at an increased risk for long-term eye complications.” The procedure also “can interfere with the detection of glaucoma” and lead to pain caused by nerve damage, The New York Times reported.

Waxler’s warning is not the first time that the alarm has been raised about LASIK. In 2008, patients who experienced adverse effects of the surgery and their families testified at an FDA meeting.

By Emma Schkloven

Emma Schkloven is an award-winning reporter based in Virginia. She graduated in 2014 with a degree in English. Her work has been picked up by The Associated Press and The Washington Post, and her bylines have appeared in The Baltimore Sun, The Las Vegas Sun and The News & Advance in Lynchburg, Virginia.

Written by

MedTruth is a digital magazine reporting on health, safety and justice. Join the revolution today at

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store